|
2026
|
G/S
|
Pharmaceuticals; medicines for human purposes; Pharmaceutical preparations; Pharmaceutical compos... |
|
|
Invention
|
Polymorphs of iptacopan hydrochloride. The present invention relates to novel polymorphic forms o... |
|
|
Invention
|
Composition for inhalation. The present invention discloses a pharmaceutical composition in the f... |
|
|
Invention
|
Polymorphs of lorlatinib. The present invention relates to novel polymorphs of Lorlatinib, design... |
|
|
Invention
|
Pharmaceutical formulation.
Soft gelatin capsules comprising a suspension composition of ninteda... |
|
|
Invention
|
Polymorphs of darolutamide. The present invention discloses novel polymorphs of Darolutamide Form... |
|
2025
|
Invention
|
Stable aqueous injectable formulation of flucytosine.
A stable, sterile, ready-to-use aqueous ph... |
|
|
Invention
|
Polymorphs of trofinetide. The present invention discloses polymorphic forms of Trofinetide and p... |
|
|
G/S
|
Pharmaceutical and medicinal preparations; Veterinary preparations; Sanitary preparations for med... |
|
|
Invention
|
Injectable composition of aprepitant. The present invention relates to an injectable composition ... |
|
|
Invention
|
Ready to use injectable compositions of metolazone. The present invention relates to injectable p... |
|
|
Invention
|
Ophthalmic composition of dexamethasone. The present invention discloses an ophthalmic compositio... |
|
|
Invention
|
Selective estrogen receptor modulator for treatment of pancreatic cancer.
Disclosed is a method ... |
|
|
Invention
|
Injectable compositions of apixaban. The present invention relates to an injectable pharmaceutica... |
|
|
Invention
|
Polymorphs of cabozantinib salts and process thereof. Disclosed herein are novel polymorphs of Ca... |
|
|
Invention
|
Novel etrasimod l-arginine polymorphs and amorphous forms and processes for the same. The present... |
|
|
Invention
|
Process for synthesis of etripamil. Disclosed herein is a short and efficient process for the pre... |
|
|
Invention
|
Novel ophthalmic gel composition. The present invention relates to a novel pharmaceutical composi... |
|
|
Invention
|
Ribociclib succinate form c and process thereof. The present invention discloses novel crystallin... |
|
|
Invention
|
Lenvatinib salts or polymorphs and process for preparation thereof. Disclosed herein are novel Le... |
|
|
Invention
|
Parenteral formulations of nimodipine. The present invention relates to stable, sterile, ready-to... |
|
2024
|
Invention
|
Ready to use injectable formulation of potassium phosphate. The present invention relates to a re... |
|
|
Invention
|
Resmetirom polymorphs and process for their preparation. Disclosed herein are polymorphs of Resme... |
|
|
Invention
|
Ready to use injectable compositions of flecainide. The present invention relates to a ready to u... |
|
|
Invention
|
Injectable compositions of flecainide.
The present invention discloses injectable pharmaceutical... |
|
|
Invention
|
Injectable compositions of flecainide. The present invention discloses injectable pharmaceutical ... |
|
|
Invention
|
Daprodustat polymorphs and processes for preparation thereof. The present invention relates to ne... |
|
|
Invention
|
Pharmaceutical combinations and compositions thereof comprising antibacterial agents. The present... |
|
|
Invention
|
Combination therapy for use in treating retroviral infections.
A pharmaceutical composition is p... |
|
|
Invention
|
Injectable compositions of metolazone |
|
|
Invention
|
Injectable compositions of metolazone. The present invention relates to injectable pharmaceutical... |
|
|
Invention
|
A safe pharmaceutical composition of hydrocortisone.
The present invention discloses an aqueous ... |
|
|
Invention
|
A safe pharmaceutical composition of hydrocortisone. The present invention discloses an aqueous p... |
|
|
Invention
|
Pharmaceutical composition of ensifentrine with pharmaceutically acceptable propellants.
Provide... |
|
|
Invention
|
Pharmaceutical composition of ensifentrine with pharmaceutically acceptable propellants |
|
|
Invention
|
Pharmaceutical composition of ensifentrine with pharmaceutically acceptable propellants. Provided... |
|
|
Invention
|
Deucravacitinib amorphous solid dispersions and polymorphs thereof. Disclosed herein is Deucravac... |
|
|
Invention
|
A method for evaluating effectiveness of drug formulations. The present invention relates to a me... |
|
|
Invention
|
Stable parenteral formulations of flucytosine.
A stable, sterile, ready-to-use aqueous pharmaceu... |
|
|
Invention
|
Sterile parenteral formulations of flucytosine. A stable, sterile, ready-to-use aqueous pharmaceu... |
|
|
Invention
|
Pharmaceutical compositions of green propellant |
|
|
Invention
|
Pharmaceutical compositions of green propellant. Described herein are compositions of pMDIs for a... |
|
2023
|
Invention
|
Stable aqueous injectable formulation of flucytosine.
The present invention relates to sterile r... |
|
|
Invention
|
Stable aqueous injectable formulation of flucytosine. The present invention relates to sterile re... |
|
|
Invention
|
Injectable compositions of celecoxib. The present invention relates to an aqueous injectable comp... |
|
|
Invention
|
Injectable compositions of posaconazole. The present invention relates to stable injectable pharm... |
|
|
Invention
|
A pharmaceutical composition of salbutamol and pharmaceutical green propellant.
Disclosed is a p... |
|
|
Invention
|
An improved process for preparing antiviral phosphonate analogues.
The present invention relates... |
|
|
G/S
|
Pharmaceutical products, preparations for medical and veterinary use; Pharmaceutical compounds; P... |
|
|
Invention
|
Solid state forms of ensifentrine.
The present invention relates to solid state forms of Ensifen... |
|
|
Invention
|
Solid state forms of ensifentrine. The present invention relates to solid state forms of Ensifent... |
|
2022
|
G/S
|
Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes;... |
|
|
Invention
|
Solid state forms of relugolix.
The present invention relates to solid state forms of Gonadotrop... |
|
|
Invention
|
Long acting injectable compositions of cariprazine or its pharmaceutically acceptable salts.
The... |
|
2020
|
G/S
|
Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of genito... |
|
|
G/S
|
Veterinary preparations; Medical preparations; Pharmaceuticals; sanitary preparations for medical... |
|
2019
|
G/S
|
Veterinary preparations; Medical preparations; Pharmaceuticals; Sanitary preparations for medical... |
|
2018
|
G/S
|
Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of gastro... |
|
2017
|
G/S
|
Pharmaceutical and veterinary preparations; Sanitary preparations for medical purposes; Dietetic ... |
|
|
G/S
|
Herbicides. Surgical and/or medical apparatus and instruments; inhalers; inhalation apparatus and... |
|
2015
|
G/S
|
Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and te... |
|
|
G/S
|
Herbicides. |
|
|
G/S
|
Medicinal and pharmaceutical product used for the treatment of schizophrenia and bipolar disorder. |
|
|
G/S
|
Food for babies; Dietary supplements for humans and animals; Plasters, materials for dressings; M... |
|
2014
|
G/S
|
Pharmaceutical and veterinary preparations; medicines for human purposes; sanitary preparations f... |
|
|
G/S
|
Medicinal and pharmaceutical preparations for respiratory disorders. Surgical, medical, dental an... |
|
|
G/S
|
Medicinal and pharmaceutical preparations for the treatment of respiratory disorders. Surgical, m... |
|
|
G/S
|
Pharmaceutical and veterinary preparations and medicines for human purposes, excluding preparatio... |
